TrkBT1 Induces Liver Metastasis of Pancreatic Cancer Cells by Sequestering Rho GDP Dissociation Inhibitor and Promoting RhoA Activation
Authors:
Open Access
- 1 October 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (19) , 7851-7859
Abstract
Many genetic and molecular alterations, such as K-ras mutation and NF-κB activation, have been identified in pancreatic cancer. However, the mechanisms by which pancreatic cancer metastasizes still remain to be determined. Although we previously showed that the tropomyosin-related kinase B (TrkB) was significantly correlated with the development of liver metastasis, its function in pancreatic cancer metastasis remained unresolved. In the present study, we showed that overexpressed TrkB is an alternatively spliced transcript variant of TrkB (TrkBT1) with a unique COOH-terminal 12–amino acid sequence and is mainly localized in the cytoplasm. Our results showed that overexpression of Flag-tagged TrkBT1 but not a Flag-tagged TrkBT1 COOH-terminal deletion mutant (Flag-TrkBT1ΔC) in nonmetastatic pancreatic cancer cells enhanced cell proliferation, promoted formation of colonies in soft agar, stimulated tumor cell invasion, and induced liver metastasis in an orthotopic xenograft mouse model of pancreatic cancer. TrkBT1 interacted with Rho GDP dissociation inhibitor (GDI) in vivo, but Flag-TrkBT1ΔC did not. Furthermore, overexpression of Flag-TrkBT1 and knockdown of RhoGDI expression by RhoGDI short hairpin RNAs promoted RhoA activation, but Flag-TrkBT1ΔC overexpression did not. Therefore, our results showed that TrkBT1 overexpression induces liver metastasis of pancreatic cancer and uncovered a unique signaling mechanism by which TrkBT1 sequesters GDI and activates RhoA signaling. [Cancer Res 2009;69(19):7851–9]Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer MetastasisCell, 2009
- DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic CancerJournal of Clinical Oncology, 2009
- LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasisMolecular Cancer Therapeutics, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- TrkB-T1 regulates the RhoA signaling and actin cytoskeleton in glioma cellsBiochemical and Biophysical Research Communications, 2006
- Correlation between RhoA overexpression and tumour progression in esophageal squamous cell carcinomaEuropean Journal of Surgical Oncology, 2005
- Stabilization of p53 Is a Novel Mechanism for Proapoptotic Function of NF-κBJournal of Biological Chemistry, 2004
- RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancerBJU International, 2003
- Analysis of the Human TrkB Gene Genomic Organization Reveals Novel TrkB Isoforms, Unusual Gene Length, and Splicing MechanismBiochemical and Biophysical Research Communications, 2002
- TTIP Is a Novel Protein That Interacts with the Truncated T1 TrkB Neurotrophin ReceptorBiochemical and Biophysical Research Communications, 2000